Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA microarrays in lymphoid malignancies.

Andreas Rosenwald1

  • 1Institute of Pathology, University of Würzburg, Würzburg, Germany. Rosenwald@mail.uni-wuerzburg.de

Oncology (Williston Park, N.Y.)
|January 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma.

Cell death discovery·2022
Same author

First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial.

HemaSphere·2022
Same author

MYC multimers shield stalled replication forks from RNA polymerase.

Nature·2022
Same author

Panel Sequencing of Primary Cutaneous B-Cell Lymphoma.

Cancers·2022
Same author

Vitamin D Receptor Expression Is Significantly Decreased in Bone Metastases Compared to Matched Primary Breast Cancer Tumours.

Cancer investigation·2022
Same author

Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA Consortium.

Cancers·2022

Gene expression profiling advances lymphoma classification by identifying distinct subtypes and predicting patient outcomes. This molecular approach enables tailored therapies for lymphoid malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Current lymphoma classification may be improved by molecular diagnosis.
  • Gene expression profiling offers insights into lymphoid malignancies.

Purpose of the Study:

  • To explore the potential of gene expression profiling in lymphoma classification and outcome prediction.
  • To identify molecular markers for tailored therapies in lymphoid malignancies.

Main Methods:

  • Utilizing cDNA microarrays for gene expression profiling.
  • Developing mathematical algorithms for outcome prediction.
  • Analyzing gene expression data in diffuse large B-cell lymphoma, mantle cell lymphoma, and B-cell chronic lymphocytic leukemia.

Main Results:

Related Experiment Videos

  • Discovery of distinct biological and clinical subtypes of diffuse large B-cell lymphoma (DLBCL).
  • Development of algorithms predicting clinical outcomes in DLBCL and mantle cell lymphoma.
  • Identification of ZAP70 as a prognostic marker in B-cell chronic lymphocytic leukemia, correlating with survival.

Conclusions:

  • Gene expression profiling can refine lymphoma classification and diagnosis.
  • Molecular characterization facilitates the development of targeted therapies for lymphoid cancers.
  • Prognostic markers identified through gene expression profiling aid in patient management.